ever
acut
respiratori
syndrom
sar
emerg
novel
infecti
disord
first
diagnos
guangdong
provinc
china
novemb
subsequ
spread
worldwid
spread
sar
via
airborn
droplet
infect
result
acut
pulmonari
inflamm
epitheli
damag
initi
outbreak
sar
document
approxim
person
global
result
death
grow
bodi
evid
proven
novel
coronaviru
etiolog
agent
sar
electron
microscop
analysi
affect
lung
tissu
reveal
distinct
structur
coronaviru
fig
genom
rna
sar
coronaviru
scov
isol
sputum
tissu
sampl
sar
patient
koch
postul
fulfil
demonstr
infect
primat
scov
result
similar
clinic
syndrom
observ
human
evid
suggest
sar
may
origin
anim
reservoir
virus
similar
scov
found
himalayan
palm
civet
sold
liveanim
market
guangdong
china
clinic
sever
sar
vari
consider
presum
genet
divers
host
immun
respons
clinic
sar
character
fever
product
cough
short
breath
myalgia
diarrhea
case
rapid
progress
lung
consolid
occur
lead
respiratori
failur
death
laboratori
abnorm
includ
elev
lactat
dehydrogenas
lymphopenia
thrombocytopenia
hypocalcemia
liver
enzym
abnorm
common
sar
patient
although
hepat
impair
report
promin
featur
ill
coronavirus
divers
group
larg
envelop
positivestrand
rna
virus
caus
broad
spectrum
diseas
includ
pneumon
hepat
nephriti
enter
enceph
anim
sever
virus
signific
veterinari
pathogen
human
coronavirus
usual
caus
upper
respiratori
enter
infect
lower
respiratori
tract
diseas
rare
three
group
coronavirus
group
classifi
base
host
rang
genom
organ
coronavirus
typic
narrow
host
rang
human
coronavirus
belong
group
group
although
scov
strictli
fall
three
group
known
coronavirus
bear
closest
resembl
group
coronavirus
also
contain
mous
hepat
viru
mhv
type
diseas
incit
given
coronaviru
influenc
age
genet
background
host
rout
infect
biolog
properti
coronaviru
serotyp
coronavirida
share
replic
transcript
featur
coronaviru
genom
singl
nonseg
rna
strand
estim
molecular
weight
million
da
coronavirus
contain
rnadepend
rna
polymeras
transcrib
posit
templat
synthes
fulllength
subgenom
neg
strand
rna
serv
templat
mrna
synthesi
polymeras
error
prone
rna
recombin
occur
high
frequenc
recombin
site
observ
throughout
genom
translat
untransl
region
result
adapt
mutabl
viral
famili
three
major
structur
protein
coronavirus
nucleocapsid
protein
transmembran
protein
surfac
spike
glycoprotein
coronavirus
group
also
hemagglutinin
esteras
protein
spike
glycoprotein
bind
receptor
host
cell
fuse
viral
envelop
host
cell
membran
individu
coronavirus
use
differ
cellular
receptor
wherea
group
coronaviru
mhv
use
murin
carcinoembryon
antigenrel
cell
adhes
molecul
member
immunoglobulin
superfamili
receptor
number
group
coronavirus
human
coronaviru
requir
zinc
metalloproteas
aminopeptidas
nucleocapsid
protein
entri
target
cell
recent
put
cell
receptor
sar
coronaviru
identifi
metallopeptidas
angiotensinconvert
enzym
issu
hepatolog
chau
et
al
describ
clinic
cours
liver
patholog
featur
three
sar
patient
liver
impair
patient
moder
mark
elev
serum
alanin
transaminas
underw
liver
biopsi
examin
biopsi
specimen
suggest
liver
impair
sar
result
scov
infect
liver
rather
factor
drug
toxic
superimpos
bacteri
sepsi
system
inflammatori
respons
three
liver
biopsi
demonstr
hepatocyt
apoptosi
two
three
mark
accumul
cell
mitosi
common
patholog
featur
includ
balloon
hepatocyt
mild
moder
lobular
lymphocyt
infiltr
revers
transcriptas
polymeras
chain
reaction
rtpcr
posit
sar
coronaviru
liver
tissu
three
patient
although
virion
could
detect
either
plaqu
assay
vero
cell
electron
microscopi
find
signific
number
cell
mitot
phase
interest
author
rais
possibl
cell
cycl
disrupt
result
scov
report
anim
experiment
model
mhv
infect
studi
liver
enzym
abnorm
report
commonli
sar
patient
elev
alanin
transaminas
common
abnorm
describ
analysi
case
sar
alanin
transaminas
elev
patient
scov
detect
mani
differ
type
tissu
infect
patient
surpris
direct
infect
liver
viru
lead
liver
enzym
abnorm
howev
first
report
associ
hepat
scov
infect
liver
patholog
featur
avail
data
mhv
may
relev
sar
specif
hepat
injuri
result
sar
although
mhv
replic
mice
certain
strain
develop
fulmin
hepat
die
wherea
other
littl
liver
patholog
featur
live
within
hour
infect
mhv
liver
suscept
mice
focal
necrot
lesion
consist
acidophil
degener
hepatocyt
nuclear
debri
spars
inflammatori
infiltr
day
infect
lesion
becam
larger
numer
associ
infiltr
polymorphonuclear
leukocyt
fig
day
confluent
necrosi
evid
day
day
lesion
dens
infiltr
mononuclear
cell
adjoin
liver
parenchyma
underw
hepatocyt
regener
evidenc
mani
mitot
figur
fig
earli
cours
diseas
virion
could
detect
plaqu
assay
electron
microscopi
day
virion
could
detect
either
assay
may
relev
report
chau
et
al
fig
defin
basi
suscept
sever
inflammatori
outcom
coronaviru
infect
obviou
implic
studi
treatment
clinic
sar
although
exact
mechan
resist
suscept
coronaviru
infect
determin
studi
shown
resist
mice
infect
lead
helper
type
domin
respons
product
interferon
neutral
antibodi
cytotox
cell
result
viral
clearanc
suscept
mice
viral
infect
result
mark
inflammatori
respons
increas
product
tumor
necrosi
factor
interleukin
associ
helper
type
cellular
immun
respons
product
nonneutr
antibodi
respons
fail
control
viral
infect
result
endotheli
cell
activ
recruit
inflammatori
cell
vasoconstrict
intravascular
thrombosi
liver
necrosi
interestingli
fibrin
thrombi
intim
swell
pulmonari
vessel
describ
autopsi
sampl
lung
sar
patient
transcript
potent
prothrombot
fibroleukin
detect
howev
paper
chau
et
al
similar
patholog
chang
note
liver
biopsi
may
reflect
factor
tropism
scov
agent
lung
distribut
densiti
receptor
scov
liver
compar
lung
tissu
well
host
genet
factor
yet
determin
fact
possibl
receptor
scov
recent
identifiedangiotensin
convert
enzym
help
clarifi
organ
suscept
infect
sar
present
effect
therapeut
strategi
develop
patient
sar
treatment
use
commonli
last
outbreak
sar
includ
ribavirin
corticosteroid
ribavirin
chosen
broad
spectrum
activ
rna
virus
steroid
antiinflammatori
properti
current
uncertain
whether
treatment
regimen
posit
impact
outcom
furthermor
use
ribavirin
associ
signific
toxic
includ
hemolysi
result
discontinu
use
kaletra
combin
lopinavir
ritonavir
two
human
immunodefici
viru
proteas
inhibitor
use
patient
sar
efficaci
medic
sar
larg
unknown
immunoglobulin
interferon
scovspecif
proteas
inhibitor
fusion
inhibitor
repres
altern
therapeut
option
treat
sar
patient
interferon
vitro
activ
sar
viru
recent
studi
suggest
may
effect
agent
shown
mhv
infect
rodent
current
unknown
whether
sar
recur
global
infect
control
effort
effect
end
first
epidem
sar
howev
sar
behav
manner
similar
coronaviru
recurr
may
season
addit
anim
reservoir
may
serv
sourc
futur
outbreak
knowledg
understand
sar
progress
rapid
rate
much
remain
unknown
new
infecti
threat
